Cribriform pattern within invasive prostate carcinoma - Revision history

Michael: vauthors

2021-03-25T17:14:02Z

vauthors

← Older revision		Revision as of 17:14, 25 March 2021
Line 7:		Line 7:

	Note:		Note:
	*In the morphologic context, ''invasive cribriform carcinoma'' may be lumped with ''intraductal carcinoma of the prostate'', as immunostains are required to differentiate.<ref name=pmid28530220>{{cite journal \|~~vauthors~~=Kweldam CF, Kümmerlin IP, Nieboer D, Steyerberg EW, Bangma CH, Incrocci L, van der Kwast TH, Roobol MJ, van Leenders GJ \|title=Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4&#61;7 prostate cancer \|journal=Mod. Pathol. \|volume=30 \|issue=8 \|pages=1126–1132 \|date=August 2017 \|pmid=28530220 \|doi=10.1038/modpathol.2017.29 \|url=}}</ref>		*In the morphologic context, ''invasive cribriform carcinoma'' may be lumped with ''intraductal carcinoma of the prostate'', as immunostains are required to differentiate.<ref name=pmid28530220>{{cite journal \|authors=Kweldam CF, Kümmerlin IP, Nieboer D, Steyerberg EW, Bangma CH, Incrocci L, van der Kwast TH, Roobol MJ, van Leenders GJ \|title=Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4&#61;7 prostate cancer \|journal=Mod. Pathol. \|volume=30 \|issue=8 \|pages=1126–1132 \|date=August 2017 \|pmid=28530220 \|doi=10.1038/modpathol.2017.29 \|url=}}</ref>

	==See also==		==See also==

Michael at 17:52, 11 September 2020

2020-09-11T17:52:38Z

← Older revision		Revision as of 17:52, 11 September 2020
Line 1:		Line 1:
	'''Cribriform pattern within invasive prostate carcinoma''' has been shown to be poor prognosticator in [[prostate cancer]].<ref>{{Cite journal \| last1 = Iczkowski \| first1 = KA. \| last2 = Paner \| first2 = GP. \| last3 = Van der Kwast \| first3 = T. \| title = The New Realization About Cribriform Prostate Cancer. \| journal = Adv Anat Pathol \| volume = 25 \| issue = 1 \| pages = 31-37 \| month = Jan \| year = 2018 \| doi = 10.1097/PAP.0000000000000168 \| PMID = 28820750 }}</ref>		'''Cribriform pattern within invasive prostate carcinoma''' has been shown to be poor prognosticator in [[prostate cancer]].<ref>{{Cite journal \| last1 = Iczkowski \| first1 = KA. \| last2 = Paner \| first2 = GP. \| last3 = Van der Kwast \| first3 = T. \| title = The New Realization About Cribriform Prostate Cancer. \| journal = Adv Anat Pathol \| volume = 25 \| issue = 1 \| pages = 31-37 \| month = Jan \| year = 2018 \| doi = 10.1097/PAP.0000000000000168 \| PMID = 28820750 }}</ref>

	~~==General==~~
	In the morphologic context, ''invasive cribriform carcinoma'' may be lumped with ''intraductal carcinoma of the prostate'', as immunostains are required to differentiate.<ref name=pmid28530220>{{cite journal \|vauthors=Kweldam CF, Kümmerlin IP, Nieboer D, Steyerberg EW, Bangma CH, Incrocci L, van der Kwast TH, Roobol MJ, van Leenders GJ \|title=Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4&#61;7 prostate cancer \|journal=Mod. Pathol. \|volume=30 \|issue=8 \|pages=1126–1132 \|date=August 2017 \|pmid=28530220 \|doi=10.1038/modpathol.2017.29 \|url=}}</ref>

	==Microscopic==		==Microscopic==
Line 8:		Line 5:
	*[[Cribriform architecture]].		*[[Cribriform architecture]].
	*Loss of basal cells.		*Loss of basal cells.

			Note:
			*In the morphologic context, ''invasive cribriform carcinoma'' may be lumped with ''intraductal carcinoma of the prostate'', as immunostains are required to differentiate.<ref name=pmid28530220>{{cite journal \|vauthors=Kweldam CF, Kümmerlin IP, Nieboer D, Steyerberg EW, Bangma CH, Incrocci L, van der Kwast TH, Roobol MJ, van Leenders GJ \|title=Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4&#61;7 prostate cancer \|journal=Mod. Pathol. \|volume=30 \|issue=8 \|pages=1126–1132 \|date=August 2017 \|pmid=28530220 \|doi=10.1038/modpathol.2017.29 \|url=}}</ref>

	==See also==		==See also==

Michael: /* Microscopic */

2020-09-11T17:28:57Z

Microscopic

← Older revision		Revision as of 17:28, 11 September 2020
Line 6:		Line 6:
	==Microscopic==		==Microscopic==
	Features:{{fact}}		Features:{{fact}}
	*Cribriform architecture.		*[[Cribriform architecture]].
	*Loss of basal cells.		*Loss of basal cells.



	==See also==		==See also==

Michael at 17:25, 11 September 2020

2020-09-11T17:25:47Z

← Older revision		Revision as of 17:25, 11 September 2020
Line 1:		Line 1:
	'''Cribriform pattern within invasive prostate carcinoma''' has been shown to be poor prognosticator in [[prostate cancer]].<ref>{{Cite journal \| last1 = Iczkowski \| first1 = KA. \| last2 = Paner \| first2 = GP. \| last3 = Van der Kwast \| first3 = T. \| title = The New Realization About Cribriform Prostate Cancer. \| journal = Adv Anat Pathol \| volume = 25 \| issue = 1 \| pages = 31-37 \| month = Jan \| year = 2018 \| doi = 10.1097/PAP.0000000000000168 \| PMID = 28820750 }}</ref>		'''Cribriform pattern within invasive prostate carcinoma''' has been shown to be poor prognosticator in [[prostate cancer]].<ref>{{Cite journal \| last1 = Iczkowski \| first1 = KA. \| last2 = Paner \| first2 = GP. \| last3 = Van der Kwast \| first3 = T. \| title = The New Realization About Cribriform Prostate Cancer. \| journal = Adv Anat Pathol \| volume = 25 \| issue = 1 \| pages = 31-37 \| month = Jan \| year = 2018 \| doi = 10.1097/PAP.0000000000000168 \| PMID = 28820750 }}</ref>

			==General==
			In the morphologic context, ''invasive cribriform carcinoma'' may be lumped with ''intraductal carcinoma of the prostate'', as immunostains are required to differentiate.<ref name=pmid28530220>{{cite journal \|vauthors=Kweldam CF, Kümmerlin IP, Nieboer D, Steyerberg EW, Bangma CH, Incrocci L, van der Kwast TH, Roobol MJ, van Leenders GJ \|title=Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4&#61;7 prostate cancer \|journal=Mod. Pathol. \|volume=30 \|issue=8 \|pages=1126–1132 \|date=August 2017 \|pmid=28530220 \|doi=10.1038/modpathol.2017.29 \|url=}}</ref>

			==Microscopic==
			Features:{{fact}}
			*Cribriform architecture.
			*Loss of basal cells.



	==See also==		==See also==

Michael: /* See also */

2018-08-28T20:52:41Z

Michael: /* See also */

2018-08-28T19:49:26Z

Michael: create

2018-04-13T20:35:16Z

create

New page

'''Cribriform pattern within invasive prostate carcinoma''' has been shown to be poor prognosticator in [[prostate cancer]].<ref>{{Cite journal | last1 = Iczkowski | first1 = KA. | last2 = Paner | first2 = GP. | last3 = Van der Kwast | first3 = T. | title = The New Realization About Cribriform Prostate Cancer. | journal = Adv Anat Pathol | volume = 25 | issue = 1 | pages = 31-37 | month = Jan | year = 2018 | doi = 10.1097/PAP.0000000000000168 | PMID = 28820750 }}</ref>

==See also==
*[[Prostate cancer grading]].

==References==
{{Reflist|1}}

[[Category:Genitourinary pathology]]

← Older revision		Revision as of 20:52, 28 August 2018
Line 4:		Line 4:
	*[[Prostate cancer grading]].		*[[Prostate cancer grading]].
	*[[Cribriform pattern]].		*[[Cribriform pattern]].
			*[[Intraductal carcinoma of the prostate]].

	==References==		==References==

← Older revision		Revision as of 19:49, 28 August 2018
Line 3:		Line 3:
	==See also==		==See also==
	*[[Prostate cancer grading]].		*[[Prostate cancer grading]].
			*[[Cribriform pattern]].

	==References==		==References==